We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Jolly, this is all a bit obvious, you aren't teaching anybody anything.
MM's ran it up this morning - was easy to sell in volume for a few sessions beforehand at a big margin spread and very hard to buy anything of any size - for the last 2 weeks.
Then it became easy to buy and harder to sell
MM's had some fun, now it is moving back to its usual channels, note that both side are higher than they were before so it is all good.
Down the stairs
went Pooh
Yes, that would be different but it looks like we're past the stage of placings to keep the lights on. Placing for a solid India contract, bring it on.
IB, never say no to a placing.
Imagine India TB falls in their lap and they say to be able to cover all of India we need to raise £20m and the business is instantly valued at £100m - not a problem with such a raise personally.
Id just hope it came with warrants :)
Congrats on todays first stupid comment JS. Trying to spread a bit of FUD? They've got funds for a year or more and judging by what's in the pipeline I very much doubt they'll need to do a raise before the income starts rolling in.
If there are no serious contracts fairly soon, there's the joy of another placing in prospect
Looks like QVH are gearing up for Bleepa...
Main duties of the job
Community Diagnostic Pathway Coordinator
An exciting opportunity has arisen to recruit a Pathway Coordinator to work within the Community Diagnostic Centre (CDC) at QVH. This role will be a key point of contact and coordination for all CDC patients under the care the breathlessness pathway and individualised diagnostic tests.
This important role will need to work closely with the QVH respiratory, cardiology and Imaging services along with clinicians, managers and other Trust staff to ensure the trust is following diagnostic pathways effectively and that patients progress through their pathway with minimal delay.
The successful candidate should have experience of working in healthcare, a good understanding of diagnostic waiting times and be willing to embrace the challenges of ensuring patients are following the optimal pathway during their care.
I can understand some serious selling if this doubles from here but if a few decent contracts hit and suddenly you have 3/4 million in revenue you are going to have a solid 40M market cap. Then you have the potential of a decent expansion roll-out or even possibly buy out. There will be some serious decision making for holders in the next few months.
Interesting to see how many weakish holders there are now
yes, v illiquid ....so won't take many derisking for the sp to deflate... slowly ofc feedback style (down the stairs; up the rocket)
FDBK lovely spike and retraced to sit on another 22%
Cheeky little spike thought by the MM's all the same.
They know everyone's expecting news so they ride it up, open the spread and then add on another 10%.
Healthy position,
good rise
more to come
Jimbos - I suspect many people are unaware of the level of institutional shareholdings in this company. Over 46% of FDBK is owned by four financial institutions. And that, I would suggest, is very unusual for a micro cap like this.
Unicorn Asset Management Limited* 18.21%
Octopus Investments Nominees Limited* 12.75%
Premier Miton Group PLC* 9.5%
Mole Valley Asset Management Ltd* 6.15%
Between them they have invested eight figure numbers here and all are sticky holders. Impressive I would say. And not a lot of free stock.
Anyone who thinks this morning was a P&D is, to be blunt, anignorant fool. No P&D gang would attempt a P&D here. I would not work because the stock is far too illiquid.
Lesson: for a successful P&D you need LIQUIDITY.
I doubt any p and d action as most holders are still way underwater and few people took advantage of the bottom. This is just readjusting for good news around the corner. Also most of the heavy hitters that hold shares in this, Unicorn etc, are also underwater. This would have to double from where we are now to see some real selling - but I get the impression that quite a few people are in this for the long term.
P & D??? Yawn!
£1.10 may indeed be the answer
roughly doubled on pure speculation
Ian12, never seen a p&d on here, never any volume. Post placing where did we get to? £1.40 first stop.
Can't sell 20k now, so illiquid as always.
7ark me, that escalated quickly, only managed another 500 at 91 then it ran away
I waited 15 minutes today to buy on order.
Couldn’t get a quote which is pretty bad on the MM
Where did the P&D take place? I missed it.
It's just the usual P&D.
Question is: without great contract news, how high?
And here’s the link to the TB article in the Indian press Barnacle ;)
https://health-economictimes-indiatimes-com.cdn.ampproject.org/c/s/health.economictimes.indiatimes.com/amp/news/industry/feedback-wins-ihw-digital-health-2024-gold-award-in-india/107449329
It’s surely implausible that having won such a relevant award that Bleepa should consequently fail to be a part of the planned TB screening programme given the acknowledgment that digital technology has to be at the heart of it.
Modri wants to eliminate TB from India by the end of 2025, a very ambitious target. He’d better get a move on then!
The partnership that Feedback has with Qure.ai is also worth noting, both for opportunities in India and the UK. From September 2021:
“We are delighted to be working with Qure.ai; …this is only the beginning to forging a pathway for a new global regime of diagnostic testing and screening. The combination of Qure.ai’s AI reporting capabilities through Bleepa’s instant and secure communications platform has the potential to provide timely, efficient and cost-effective care across a number of clinical settings.
“We are particularly excited to be working on screening for TB and to help deliver this to even the remotest of locations. We have the potential here to build true access to healthcare for all in India. Although we are looking at India initially, Qure.ai are a great partner and their technologies hold just as much benefit here in the UK and we are excited to explore a number of opportunities for the technologies within the NHS and UK private market. ”
“We are delighted to be working with Qure.ai; …this is only the beginning to forging a pathway for a new global regime of diagnostic testing and screening. The combination of Qure.ai’s AI reporting capabilities through Bleepa’s instant and secure communications platform has the potential to provide timely, efficient and cost-effective care across a number of clinical settings.
“We are particularly excited to be working on screening for TB and to help deliver this to even the remotest of locations. We have the potential here to build true access to healthcare for all in India. Although we are looking at India initially, Qure.ai are a great partner and their technologies hold just as much benefit here in the UK and we are excited to explore a number of opportunities for the technologies within the NHS and UK private market. ”
FEEDBACK WINS IHW GOLD AWARD - SUPPORTING TB SCREENING PROGRAMMES IN RURAL COMMUNITIES, Jan 2024
Bleepa uses local mobile networks to securely push X-rays, acquired in rural settings, to a dedicated cloud environment where they can be processed by AI to assist interpretation. Specialists can review the images using Bleepa’s in-app clinical grade image viewer and chat directly with the care team in the rural setting to reach the correct management plan for the patient, supported by the AI-generated report.
Bleepa connects with Qure.ai’s AI platform so the images can be processed and interpreted, returning the results within a matter of minutes. This helps the radiologist to triage the scan and flag any abnormalities which would indicate a TB diagnosis.
Since the start of the project in March 2022 nearly 2,000 patients have been screened at the hospital, with 19.6% of scans coming back as indicating positive for signs of TB.
All looking very rosy, just a shame the mms don't make a market. Still can't get a quote to buy anything at all, not even £100s worth!